{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:48:03Z","timestamp":1791582483871,"version":"4.3.4"},"reference-count":141,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,6,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma cell dyscrasia that consistently precedes multiple myeloma (MM) with a 1% risk of progression per year. Recent advances have improved understanding of the complex genetic and immunologic factors that permit progression from the aberrant plasma cell clone to MGUS and overt MM. Additional evidence supports bidirectional interaction of MGUS cells with surrounding cells in the bone marrow niche that regulates malignant transformation. However, there are no robust prognostic biomarkers. Herein we review the current body of literature on the biology of MGUS and provide a rationale for the improved identification of high-risk MGUS patients who may be appropriate for novel clinical interventions to prevent progression or eradicate premalignant clones prior to the development of overt MM.<\/jats:p>","DOI":"10.1182\/blood.2019846782","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T19:16:02Z","timestamp":1555960562000},"page":"2484-2494","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":84,"title":["Monoclonal gammopathy of undetermined significance"],"prefix":"10.1182","volume":"133","author":[{"given":"Tarek H.","family":"Mouhieddine","sequence":"first","affiliation":[{"name":"The Center for Prevention of Progression of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachelle D.","family":"Weeks","sequence":"additional","affiliation":[{"name":"The Center for Prevention of Progression of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Ghobrial","sequence":"additional","affiliation":[{"name":"The Center for Prevention of Progression of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"22","key":"2020021109204883600_B1","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2020021109204883600_B2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4065\/mcp.2010.0520","article-title":"Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence","volume":"85","author":"Rajkumar","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"2020021109204883600_B3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"2020021109204883600_B4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3816\/CLML.2011.n.011","article-title":"IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenstr\u00f6m\u2019s macroglobulinemia (SWM)","volume":"11","author":"Kyle","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"2020021109204883600_B5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working Group","year":"2003","journal-title":"Br J Haematol"},{"issue":"6","key":"2020021109204883600_B6","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"issue":"9727","key":"2020021109204883600_B7","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"issue":"23","key":"2020021109204883600_B8","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood-2016-09-692954","article-title":"MGUS to myeloma: a mysterious gammopathy of underexplored significance","volume":"128","author":"Dhodapkar","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2020021109204883600_B9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.0954-6820.1963.tb17460.x","article-title":"Frequency of \u201cabnormal\u201d serum globulins (M-components) in the aged","volume":"173","author":"Hallen","year":"1963","journal-title":"Acta Med Scand"},{"issue":"2","key":"2020021109204883600_B10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.0954-6820.1966.tb05453.x","article-title":"Frequency of pathological proteins (M-components) om 6,995 sera from an adult population","volume":"179","author":"Axelsson","year":"1966","journal-title":"Acta Med Scand"},{"issue":"5","key":"2020021109204883600_B11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood.V40.5.719.719","article-title":"Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma","volume":"40","author":"Kyle","year":"1972","journal-title":"Blood"},{"issue":"13","key":"2020021109204883600_B12","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"2020021109204883600_B13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0609.1992.tb01584.x","article-title":"Occurrence of monoclonal components in general practice: clinical implications","volume":"48","author":"Aguzzi","year":"1992","journal-title":"Eur J Haematol"},{"issue":"1","key":"2020021109204883600_B14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jcp.35.1.63","article-title":"Monoclonal gammopathies in the adult population of Finist\u00e8re, France","volume":"35","author":"Saleun","year":"1982","journal-title":"J Clin Pathol"},{"issue":"5","key":"2020021109204883600_B15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9343(98)00080-1","article-title":"Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly","volume":"104","author":"Cohen","year":"1998","journal-title":"Am J Med"},{"issue":"7","key":"2020021109204883600_B16","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey","volume":"28","author":"Landgren","year":"2014","journal-title":"Leukemia"},{"issue":"3","key":"2020021109204883600_B17","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"issue":"12","key":"2020021109204883600_B18","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0025-6196(11)61089-6","article-title":"Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana","volume":"82","author":"Landgren","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"2020021109204883600_B19","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/leu.2009.134","article-title":"Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic\/racial groups: support for genetic factors in pathogenesis","volume":"23","author":"Landgren","year":"2009","journal-title":"Leukemia"},{"issue":"3","key":"2020021109204883600_B20","first-page":"177","article-title":"HLA and multiple myeloma among black and white men: evidence of a genetic association","volume":"1","author":"Pottern","year":"1992","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"2020021109204883600_B21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ajh.22025","article-title":"Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients","volume":"86","author":"Weiss","year":"2011","journal-title":"Am J Hematol"},{"issue":"25","key":"2020021109204883600_B22","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2020021109204883600_B23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"issue":"7","key":"2020021109204883600_B24","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","article-title":"Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"},{"issue":"24","key":"2020021109204883600_B25","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1182\/blood-2011-04-347559","article-title":"Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study","volume":"118","author":"Lindqvist","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2020021109204883600_B26","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/sj.leu.2400875","article-title":"Paraproteinemia, plasmacytoma, myeloma and HIV infection","volume":"11","author":"Fiorino","year":"1997","journal-title":"Leukemia"},{"issue":"7","key":"2020021109204883600_B27","first-page":"372","article-title":"Plasma cell disorders in HIV-infected patients: from benign gammopathy to multiple myeloma","volume":"14","author":"Dezube","year":"2004","journal-title":"AIDS Read"},{"issue":"8","key":"2020021109204883600_B28","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/clinchem\/35.8.1669","article-title":"Oligoclonal immunoglobulins in HIV infection","volume":"35","author":"Sinclair","year":"1989","journal-title":"Clin Chem"},{"issue":"1","key":"2020021109204883600_B29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/B:CACO.0000016573.79453.ba","article-title":"Obesity and cancer risk among white and black United States veterans","volume":"15","author":"Samanic","year":"2004","journal-title":"Cancer Causes Control"},{"issue":"7","key":"2020021109204883600_B30","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","article-title":"Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women","volume":"116","author":"Landgren","year":"2010","journal-title":"Blood"},{"issue":"24","key":"2020021109204883600_B31","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/bloodadvances.2017007609","article-title":"Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study","volume":"1","author":"Thordardottir","year":"2017","journal-title":"Blood Adv"},{"issue":"5","key":"2020021109204883600_B32","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw264","article-title":"Obesity and the transformation of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based cohort study","volume":"109","author":"Chang","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2020021109204883600_B33","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S2352-3026(14)00037-4","article-title":"Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study","volume":"2","author":"Chang","year":"2015","journal-title":"Lancet Haematol"},{"issue":"8","key":"2020021109204883600_B34","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood-2008-05-159665","article-title":"Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors","volume":"113","author":"Iwanaga","year":"2009","journal-title":"Blood"},{"issue":"12","key":"2020021109204883600_B35","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0025-6196(11)61090-2","article-title":"Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan","volume":"82","author":"Iwanaga","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"25","key":"2020021109204883600_B36","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1182\/blood-2009-02-203471","article-title":"Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2020021109204883600_B37","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jamaoncol.2015.2938","article-title":"Agent Orange exposure and monoclonal gammopathy of undetermined significance: an Operation Ranch Hand veteran cohort study","volume":"1","author":"Landgren","year":"2015","journal-title":"JAMA Oncol"},{"key":"2020021109204883600_B38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.envint.2017.08.007","article-title":"Is long-term particulate matter and nitrogen dioxide air pollution associated with incident monoclonal gammopathy of undetermined significance (MGUS)? An analysis of the Heinz Nixdorf Recall study","volume":"108","author":"Orban","year":"2017","journal-title":"Environ Int"},{"issue":"6","key":"2020021109204883600_B39","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamaoncol.2018.0509","article-title":"Multiple myeloma and its precursor disease among firefighters exposed to the World Trade Center disaster","volume":"4","author":"Landgren","year":"2018","journal-title":"JAMA Oncol"},{"issue":"7","key":"2020021109204883600_B40","doi-asserted-by":"crossref","first-page":"e40016","DOI":"10.1371\/journal.pone.0040016","article-title":"Comparison of WTC dust size on macrophage inflammatory cytokine release in vivo and in vitro","volume":"7","author":"Weiden","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"2020021109204883600_B41","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/art.39059","article-title":"Nested case-control study of selected systemic autoimmune diseases in World Trade Center rescue\/recovery workers","volume":"67","author":"Webber","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"2020021109204883600_B42","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.06-2114","article-title":"World Trade Center \u201csarcoid-like\u201d granulomatous pulmonary disease in New York City Fire Department rescue workers","volume":"131","author":"Izbicki","year":"2007","journal-title":"Chest"},{"issue":"2","key":"2020021109204883600_B43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJMoa0708704","article-title":"Familial myeloma","volume":"359","author":"Lynch","year":"2008","journal-title":"N Engl J Med"},{"issue":"12","key":"2020021109204883600_B44","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1002\/ijc.21745","article-title":"Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study","volume":"118","author":"Landgren","year":"2006","journal-title":"Int J Cancer"},{"issue":"4","key":"2020021109204883600_B45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2008-12-191676","article-title":"Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden","volume":"114","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2020021109204883600_B46","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1470-2045(09)70234-7","article-title":"Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study","volume":"10","author":"Grass","year":"2009","journal-title":"Lancet Oncol"},{"issue":"3","key":"2020021109204883600_B47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood-2011-01-331454","article-title":"Paraproteins of familial MGUS\/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS\/MM","volume":"118","author":"Grass","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2020021109204883600_B48","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1600-0609.2011.01593.x","article-title":"Familial monoclonal gammopathy: hyper-responsive B cells in unaffected family members","volume":"86","author":"Steingr\u00edmsd\u00f3ttir","year":"2011","journal-title":"Eur J Haematol"},{"issue":"4","key":"2020021109204883600_B49","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ijc.28731","article-title":"Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS\/MM","volume":"135","author":"Zwick","year":"2014","journal-title":"Int J Cancer"},{"issue":"6","key":"2020021109204883600_B50","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2141.2012.09244.x","article-title":"Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma","volume":"158","author":"Martino","year":"2012","journal-title":"Br J Haematol"},{"issue":"1","key":"2020021109204883600_B51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ng.993","article-title":"Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk","volume":"44","author":"Broderick","year":"2011","journal-title":"Nat Genet"},{"issue":"10","key":"2020021109204883600_B52","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/ng.2733","article-title":"Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk","volume":"45","author":"Chubb","year":"2013","journal-title":"Nat Genet"},{"issue":"Pt 12","key":"2020021109204883600_B53","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1242\/jcs.02995","article-title":"Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin","volume":"119","author":"Maertens","year":"2006","journal-title":"J Cell Sci"},{"issue":"6","key":"2020021109204883600_B54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","article-title":"Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma","volume":"132","author":"Walker","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2020021109204883600_B55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s10020-018-0031-8","article-title":"Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study","volume":"24","author":"Chattopadhyay","year":"2018","journal-title":"Mol Med"},{"issue":"9","key":"2020021109204883600_B56","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3324\/haematol.2017.163766","article-title":"The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma","volume":"102","author":"Mikulasova","year":"2017","journal-title":"Haematologica"},{"key":"2020021109204883600_B57","doi-asserted-by":"crossref","first-page":"209670","DOI":"10.1155\/2014\/209670","article-title":"Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience","volume":"2014","author":"Smetana","year":"2014","journal-title":"BioMed Res Int"},{"issue":"12","key":"2020021109204883600_B58","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/leu.2012.128","article-title":"SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status","volume":"26","author":"L\u00f3pez-Corral","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"2020021109204883600_B59","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1309\/6U88-357U-UKJ5-YPT3","article-title":"Cytogenetic findings in lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course","volume":"116","author":"Mansoor","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"15","key":"2020021109204883600_B60","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood-2014-09-602565","article-title":"The cellular origin and malignant transformation of Waldenstr\u00f6m macroglobulinemia","volume":"125","author":"Paiva","year":"2015","journal-title":"Blood"},{"issue":"2","key":"2020021109204883600_B61","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cancergencyto.2006.04.009","article-title":"6q deletion discriminates Waldenstr\u00f6m macroglobulinemia from IgM monoclonal gammopathy of undetermined significance","volume":"169","author":"Schop","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"issue":"18","key":"2020021109204883600_B62","first-page":"4546","article-title":"14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du My\u00e9lome","volume":"59","author":"Avet-Loiseau","year":"1999","journal-title":"Cancer Res"},{"issue":"4","key":"2020021109204883600_B63","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","article-title":"Genomic abnormalities in monoclonal gammopathy of undetermined significance","volume":"100","author":"Fonseca","year":"2002","journal-title":"Blood"},{"issue":"12","key":"2020021109204883600_B64","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3324\/haematol.2009.011064","article-title":"Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context","volume":"94","author":"Chiecchio","year":"2009","journal-title":"Haematologica"},{"issue":"7","key":"2020021109204883600_B65","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1158\/1078-0432.CCR-10-1066","article-title":"The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells","volume":"17","author":"L\u00f3pez-Corral","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2020021109204883600_B66","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood.V99.6.2185","article-title":"Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation","volume":"99","author":"Avet-Loiseau","year":"2002","journal-title":"Blood"},{"issue":"12","key":"2020021109204883600_B67","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3324\/haematol.2017.172718","article-title":"Pattern of somatic mutations in patients with Waldenstr\u00f6m macroglobulinemia or IgM monoclonal gammopathy of undetermined significance","volume":"102","author":"Varettoni","year":"2017","journal-title":"Haematologica"},{"issue":"17","key":"2020021109204883600_B68","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood-2012-12-471888","article-title":"Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells","volume":"121","author":"Walker","year":"2013","journal-title":"Blood"},{"issue":"10","key":"2020021109204883600_B69","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.3324\/haematol.2010.024778","article-title":"Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma","volume":"95","author":"Rasmussen","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"2020021109204883600_B70","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1182\/blood-2006-07-037077","article-title":"Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis","volume":"109","author":"Zhan","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2020021109204883600_B71","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","article-title":"A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1","volume":"109","author":"Shaughnessy","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2020021109204883600_B72","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2013-07-515239","article-title":"Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)","volume":"123","author":"Dhodapkar","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2020021109204883600_B73","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2005-01-0034","article-title":"Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma","volume":"106","author":"Bergsagel","year":"2005","journal-title":"Blood"},{"issue":"7","key":"2020021109204883600_B74","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2003-02-0493","article-title":"The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma","volume":"102","author":"Fonseca","year":"2003","journal-title":"Blood"},{"issue":"35","key":"2020021109204883600_B75","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.0806202105","article-title":"MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis","volume":"105","author":"Pichiorri","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5654","key":"2020021109204883600_B76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.1091903","article-title":"MicroRNAs modulate hematopoietic lineage differentiation","volume":"303","author":"Chen","year":"2004","journal-title":"Science"},{"issue":"3","key":"2020021109204883600_B77","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3324\/haematol.2013.093500","article-title":"Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"99","author":"Kubiczkova","year":"2014","journal-title":"Haematologica"},{"issue":"2","key":"2020021109204883600_B78","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00277-009-0818-3","article-title":"DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance","volume":"89","author":"Stanganelli","year":"2010","journal-title":"Ann Hematol"},{"issue":"12","key":"2020021109204883600_B79","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.clml.2016.08.016","article-title":"Aberrant p15, p16, p53, and DAPK gene methylation in myelomagenesis: clinical and prognostic implications","volume":"16","author":"Geraldes","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"2020021109204883600_B80","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/cncr.20295","article-title":"DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies","volume":"100","author":"Seidl","year":"2004","journal-title":"Cancer"},{"issue":"3","key":"2020021109204883600_B81","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.yexmp.2008.02.003","article-title":"Aberrant gene promoter methylation in plasma cell dyscrasias","volume":"84","author":"Martin","year":"2008","journal-title":"Exp Mol Pathol"},{"issue":"3","key":"2020021109204883600_B82","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/leu.2008.336","article-title":"Pathogenesis of myeloma bone disease","volume":"23","author":"Roodman","year":"2009","journal-title":"Leukemia"},{"issue":"5","key":"2020021109204883600_B83","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2141.2004.05092.x","article-title":"Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS)","volume":"126","author":"Politou","year":"2004","journal-title":"Br J Haematol"},{"issue":"15","key":"2020021109204883600_B84","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood-2010-04-282848","article-title":"Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study","volume":"116","author":"Kristinsson","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2020021109204883600_B85","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"issue":"12","key":"2020021109204883600_B86","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1080\/10428190701648281","article-title":"Myeloma cells and bone marrow osteoblast interactions: role in the development of osteolytic lesions in multiple myeloma","volume":"48","author":"Giuliani","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"2020021109204883600_B87","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12578","article-title":"The osteoblastic niche in the context of multiple myeloma","volume":"1335","author":"Toscani","year":"2015","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"2020021109204883600_B88","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1359\/jbmr.2002.17.11.1921","article-title":"Role of the bone marrow microenvironment in multiple myeloma","volume":"17","author":"Roodman","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2020021109204883600_B89","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.beha.2007.08.002","article-title":"The malignant clone and the bone-marrow environment","volume":"20","author":"Podar","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"2020021109204883600_B90","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1078-0432.CCR-11-2212","article-title":"Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects","volume":"18","author":"Reagan","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2020021109204883600_B91","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.exphem.2009.11.009","article-title":"Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease","volume":"38","author":"Todoerti","year":"2010","journal-title":"Exp Hematol"},{"issue":"25","key":"2020021109204883600_B92","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1200\/JCO.2008.19.1916","article-title":"Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma","volume":"27","author":"Anguiano","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"2020021109204883600_B93","first-page":"26","article-title":"Role of endothelial progenitor cells in cancer progression","volume":"1846","author":"Moschetta","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"2020021109204883600_B94","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/leu.2010.193","article-title":"Low bone marrow oxygen tension and hypoxia-inducible factor-1\u03b1 overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138(+) cells","volume":"24","author":"Colla","year":"2010","journal-title":"Leukemia"},{"issue":"24","key":"2020021109204883600_B95","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1182\/blood-2011-09-380410","article-title":"Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features","volume":"119","author":"Azab","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2020021109204883600_B96","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1021\/pr400881p","article-title":"Extracellular matrix remodeling by bone marrow fibroblast-like cells correlates with disease progression in multiple myeloma","volume":"13","author":"Slany","year":"2014","journal-title":"J Proteome Res"},{"issue":"11","key":"2020021109204883600_B97","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1038\/leu.2017.102","article-title":"Proteomic characterization of human multiple myeloma bone marrow extracellular matrix","volume":"31","author":"Glavey","year":"2017","journal-title":"Leukemia"},{"issue":"6","key":"2020021109204883600_B98","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/cncr.21746","article-title":"Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic\/Th1 T cells demonstrating a squed TCR-Vbeta repertoire","volume":"106","author":"P\u00e9rez-Andres","year":"2006","journal-title":"Cancer"},{"issue":"11","key":"2020021109204883600_B99","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1084\/jem.20031030","article-title":"Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy","volume":"198","author":"Dhodapkar","year":"2003","journal-title":"J Exp Med"},{"issue":"12","key":"2020021109204883600_B100","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1084\/jem.20021650","article-title":"A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma","volume":"197","author":"Dhodapkar","year":"2003","journal-title":"J Exp Med"},{"issue":"3","key":"2020021109204883600_B101","first-page":"99","article-title":"Natural killer cell frequency and function in patients with monoclonal gammopathies","volume":"37","author":"Famularo","year":"1992","journal-title":"J Clin Lab Immunol"},{"issue":"6","key":"2020021109204883600_B102","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00262-009-0807-3","article-title":"Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked","volume":"59","author":"von Lilienfeld-Toal","year":"2010","journal-title":"Cancer Immunol Immunother"},{"issue":"7090","key":"2020021109204883600_B103","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"1","key":"2020021109204883600_B104","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1471-2407-10-198","article-title":"Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays","volume":"10","author":"Mahtouk","year":"2010","journal-title":"BMC Cancer"},{"issue":"5","key":"2020021109204883600_B105","doi-asserted-by":"crossref","first-page":"e35981","DOI":"10.1371\/journal.pone.0035981","article-title":"Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent","volume":"7","author":"Feyler","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"2020021109204883600_B106","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2141.2008.07530.x","article-title":"CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) double negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden","volume":"144","author":"Feyler","year":"2009","journal-title":"Br J Haematol"},{"issue":"6","key":"2020021109204883600_B107","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1172\/JCI88169","article-title":"Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression","volume":"128","author":"Kawano","year":"2018","journal-title":"J Clin Invest"},{"issue":"1","key":"2020021109204883600_B108","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2006-10-051482","article-title":"Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-gamma and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway","volume":"110","author":"Liu","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2020021109204883600_B109","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/leu.2012.213","article-title":"Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma","volume":"27","author":"Tamura","year":"2013","journal-title":"Leukemia"},{"issue":"13","key":"2020021109204883600_B110","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2010-02-271874","article-title":"The PD-1\/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody","volume":"116","author":"Benson","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2020021109204883600_B111","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nm.4202","article-title":"Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice","volume":"22","author":"Das","year":"2016","journal-title":"Nat Med"},{"issue":"6","key":"2020021109204883600_B112","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3324\/haematol.2011.054015","article-title":"Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study","volume":"97","author":"Kristinsson","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"2020021109204883600_B113","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2141.2006.06269.x","article-title":"Fracture risk in patients with monoclonal gammopathy of undetermined significance","volume":"135","author":"Gregersen","year":"2006","journal-title":"Br J Haematol"},{"issue":"5","key":"2020021109204883600_B114","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.mayocp.2017.02.003","article-title":"Monoclonal gammopathy-associated peripheral neuropathy: diagnosis and management","volume":"92","author":"Chaudhry","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"2020021109204883600_B115","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood-2008-04-151076","article-title":"Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma","volume":"112","author":"Kristinsson","year":"2008","journal-title":"Blood"},{"issue":"22","key":"2020021109204883600_B116","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","article-title":"How I treat monoclonal gammopathy of renal significance (MGRS)","volume":"122","author":"Fermand","year":"2013","journal-title":"Blood"},{"issue":"22","key":"2020021109204883600_B117","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V114.22.1852.1852","article-title":"Lack of response to vaccination in MGUS and stable myeloma [abstract]","volume":"114","author":"Prabhala","year":"2009","journal-title":"Blood"},{"issue":"27","key":"2020021109204883600_B118","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/bloodadvances.2017010454","article-title":"Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study","volume":"1","author":"Thorsteinsdottir","year":"2017","journal-title":"Blood Adv"},{"issue":"5","key":"2020021109204883600_B119","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1182\/blood-2013-05-505776","article-title":"Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance","volume":"123","author":"Farr","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2020021109204883600_B120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.410300111","article-title":"Neuropathy associated with monoclonal gammopathies of undetermined significance","volume":"30","author":"Gosselin","year":"1991","journal-title":"Ann Neurol"},{"issue":"1","key":"2020021109204883600_B121","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12883-016-0532-4","article-title":"Paraproteinemic neuropathy: a practical review","volume":"16","author":"Rison","year":"2016","journal-title":"BMC Neurol"},{"issue":"22","key":"2020021109204883600_B122","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2020021109204883600_B123","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.2009010110","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits","volume":"20","author":"Nasr","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2020021109204883600_B124","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0272-6386(12)80314-3","article-title":"Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease","volume":"20","author":"Heilman","year":"1992","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2020021109204883600_B125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.kint.2018.01.028","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft","volume":"94","author":"Said","year":"2018","journal-title":"Kidney Int"},{"issue":"26","key":"2020021109204883600_B126","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1182\/blood-2015-07-658872","article-title":"Natural history and outcome of light chain deposition disease","volume":"126","author":"Sayed","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2020021109204883600_B127","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"issue":"7","key":"2020021109204883600_B128","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood-2007-05-088443","article-title":"New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells","volume":"110","author":"P\u00e9rez-Persona","year":"2007","journal-title":"Blood"},{"key":"2020021109204883600_B129","unstructured":"ClinicalTrials.gov\n          . Iceland screens, treats or prevents multiple myeloma (iStopMM). Identifier NCT03327597. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03327597. Accessed 1 January 2019."},{"key":"2020021109204883600_B130","unstructured":"ClinicalTrials.gov\n          . Predicting progression of developing myeloma in a high-risk screened population (PROMISE). Identifier NCT03689595. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03689595. Accessed 1 January 2019."},{"issue":"2","key":"2020021109204883600_B131","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jamaoncol.2015.23","article-title":"The role of diagnosis and clinical follow-up of monoclonal gammopathy of undetermined significance on survival in multiple myeloma","volume":"1","author":"Sigurdardottir","year":"2015","journal-title":"JAMA Oncol"},{"issue":"12","key":"2020021109204883600_B132","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2010-04-277566","article-title":"Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications","volume":"116","author":"Bianchi","year":"2010","journal-title":"Blood"},{"issue":"9","key":"2020021109204883600_B133","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"2020021109204883600_B134","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4065\/82.4.428","article-title":"Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size","volume":"82","author":"Rosi\u00f1ol","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"2020021109204883600_B135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archinte.1989.00390020080016","article-title":"Peripheral neuropathy as an early marker of AL amyloidosis","volume":"149","author":"Duston","year":"1989","journal-title":"Arch Intern Med"},{"issue":"4","key":"2020021109204883600_B136","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2141.1993.tb04714.x","article-title":"Complete remission of paraproteinaemia and neuropathy following iatrogenic oral melphalan overdose","volume":"83","author":"Grimes","year":"1993","journal-title":"Br J Haematol"},{"issue":"1","key":"2020021109204883600_B137","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.bmt.1703582","article-title":"Autologous peripheral blood stem cell transplantation for peripheral neuropathy secondary to monoclonal gammopathy of unknown significance","volume":"30","author":"Lee","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2020021109204883600_B138","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbmt.2017.08.031","article-title":"High-dose melphalan and stem cell transplantation in patients on dialysis due to immunoglobulin light-chain amyloidosis and monoclonal immunoglobulin deposition disease","volume":"24","author":"Batalini","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"18","key":"2020021109204883600_B139","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.1158\/1078-0432.CCR-08-2217","article-title":"The potential role of curcumin in patients with monoclonal gammopathy of undefined significance\u2013its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker","volume":"15","author":"Golombick","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2020021109204883600_B140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/1940-6207.CAPR-13-0224","article-title":"Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses\u2019 health study","volume":"7","author":"Birmann","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"2020021109204883600_B141","unstructured":"ClinicalTrials.gov\n          . Phase II study of the CD38 antibody daratumumab in patients with high-risk MGUS and low-risk smoldering multiple myeloma. Identifier NCT03236428. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03236428. Accessed 1 January 2019."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/133\/23\/2484\/1553607\/bloodbld2019846782c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/133\/23\/2484\/1553607\/bloodbld2019846782c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T09:59:04Z","timestamp":1581415144000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/133\/23\/2484\/273836\/Monoclonal-gammopathy-of-undetermined-significance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":141,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2019,6,6]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019846782","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]}}}